Changes in the treatment of Pancoast tumors

Ann Thorac Surg. 2003 Jun;75(6):1990-7. doi: 10.1016/s0003-4975(03)00134-6.

Abstract

Our understanding of superior sulcus tumors has evolved over time. The unique feature of Pancoast tumors is their location, in which the anatomy poses limitations to resection. Many resections are found to be incomplete, and the majority of recurrences have involved local failure. New surgical approaches allow greater flexibility according to tumor location and may improve these outcomes. Furthermore, new approaches permit complete resection of tumors involving vertebral bodies or the neural foramina. Traditionally, preoperative radiotherapy has been used, but a recent prospective phase II study suggests that preoperative concurrent chemoradiotherapy improves the rate of complete resection, local recurrence, and intermediate-term survival.

Publication types

  • Review

MeSH terms

  • Clinical Trials, Phase II as Topic
  • Combined Modality Therapy
  • Humans
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / mortality
  • Lung Neoplasms / radiotherapy
  • Lung Neoplasms / surgery*
  • Neoadjuvant Therapy*
  • Neoplasm Invasiveness
  • Pancoast Syndrome / drug therapy
  • Pancoast Syndrome / mortality
  • Pancoast Syndrome / radiotherapy
  • Pancoast Syndrome / surgery*
  • Pneumonectomy / methods
  • Prospective Studies
  • Survival Rate
  • Thoracic Neoplasms / drug therapy
  • Thoracic Neoplasms / mortality
  • Thoracic Neoplasms / radiotherapy
  • Thoracic Neoplasms / surgery*
  • Thoracotomy / methods